Hefei Lifeon Pharmaceutical Co Ltd (003020) — Net Asset Quality Index
Hefei Lifeon Pharmaceutical Co Ltd (003020) has a Net Asset Quality Index of 75.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.61 Billion minus total liabilities of CN¥634.92 Million yields net assets of CN¥1.98 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 003020 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hefei Lifeon Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2012–2025)
This chart shows how Hefei Lifeon Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2025. As of June 2026, the index stands at 75.7%, representing net assets of CN¥1.98 Billion against total assets of CN¥2.61 Billion CNY. For live market cap and overall valuation, see 003020 market cap overview.
Annual Net Asset Quality Index for Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Hefei Lifeon Pharmaceutical Co Ltd (003020) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 75.5% | CN¥1.95 Billion | CN¥2.59 Billion | CN¥634.19 Million | ▲ +1.5 pp |
| 2024 | 74.0% | CN¥1.91 Billion | CN¥2.59 Billion | CN¥673.38 Million | ▼ -1.5 pp |
| 2023 | 75.4% | CN¥1.87 Billion | CN¥2.48 Billion | CN¥610.18 Million | ▲ +5.7 pp |
| 2022 | 69.8% | CN¥1.48 Billion | CN¥2.12 Billion | CN¥641.53 Million | ▼ -8.1 pp |
| 2021 | 77.9% | CN¥1.30 Billion | CN¥1.67 Billion | CN¥370.53 Million | ▲ +1.4 pp |
| 2020 | 76.4% | CN¥1.17 Billion | CN¥1.54 Billion | CN¥362.03 Million | ▲ +10.1 pp |
| 2019 | 66.3% | CN¥590.00 Million | CN¥889.81 Million | CN¥299.82 Million | ▲ +0.7 pp |
| 2018 | 65.6% | CN¥505.70 Million | CN¥771.01 Million | CN¥265.31 Million | ▲ +6.6 pp |
| 2017 | 59.0% | CN¥361.71 Million | CN¥612.85 Million | CN¥251.14 Million | ▲ +4.6 pp |
| 2016 | 54.4% | CN¥298.09 Million | CN¥547.80 Million | CN¥249.71 Million | ▲ +9.1 pp |
| 2014 | 45.3% | CN¥215.53 Million | CN¥475.64 Million | CN¥260.11 Million | ▲ +5.7 pp |
| 2013 | 39.6% | CN¥176.88 Million | CN¥446.22 Million | CN¥269.34 Million | ▲ +0.1 pp |
| 2012 | 39.6% | CN¥141.96 Million | CN¥358.64 Million | CN¥216.67 Million | — |